Award details

Structure-based inhibitor design and vaccine development using carbohydrate-binding bacterial toxins

ReferenceSBD07527
Principal Investigator / Supervisor Professor Steve Homans
Co-Investigators /
Co-Supervisors
Dr Rob Field, Professor James Naismith, Professor Richard Randall
Institution University of Leeds
DepartmentInst of Molecular & Cellular Biology
Funding typeResearch
Value (£) 236,406
StatusCompleted
TypeResearch Grant
Start date 01/10/1997
End date 01/04/2001
Duration42 months

Abstract

Enteropathogenic Escherichia coli, in common with a variety of other pathogenic bacteria produce cytotoxins associated with diarrhoeal diseases. In addition to presenting serious problems in the Third World, these toxins are responsible for conditions such as haemolytic uraemic syndrome (HUS) in infants, which is the largest cause of kidney failure in this age group. We plan to use structural information on the carbohydrate-binding B subunits of these toxins in a multidisciplinary programme aimed at inhibitor design and to exploit the carbohydrate-binding activity of these toxins as a general tool in the design of potential mucosal vaccines.

Summary

unavailable
Committee Closed Committee - Biomolecular Sciences (BMS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative Structural biology and design applications (SBD) [1996]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file